Crossmark

What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.11.002

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Murias, Sara

Boteanu, Alina

Calvo, Inmaculada

Nuñez, Esmeralda

Bravo, Beatriz

Bustabad, Sagrario

Camacho, Marisol

Clemente, Daniel

Graña, Jenaro

de Inocencio, Jaime

Lacruz, Lucía

Mesa-del-Castillo, Pablo

Nieto-González, Juan Carlos

Pinedo, María del Carmen

Quesada, Estefanía

Vargas, Carmen

Antón, Jordi
License Information

Text and Data Mining valid from 2023-01-01
More Information

This article is maintained by: Elsevier

Article Title: What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.11.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2021.12.003

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.